Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients
Clinical trial NCT02002221 · COMPLETED
Trial details
- NCT number
- NCT02002221
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-02-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.